Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

Abstract Objectives To assess the safety and therapeutic effects of allogeneic human dental pulp stem cells (DPSCs) in treating severe pneumonia caused by COVID-19. Trial design This is a single centre, two arm ratio 1:1, triple blinded, randomized, placebo-controlled, parallel group, clinical trial...

Full description

Bibliographic Details
Main Authors: Qingsong Ye, Hua Wang, Xia Xia, Chenliang Zhou, Zhiming Liu, Zun-en Xia, Zhan Zhang, Yang Zhao, Jun Yehenala, Si Wang, Gangqiao Zhou, Ke Hu, Bin Wu, Chu-Tse Wu, Songling Wang, Yan He
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
Online Access:http://link.springer.com/article/10.1186/s13063-020-04380-5

Internet

http://link.springer.com/article/10.1186/s13063-020-04380-5

Similar Items